On Thu, May 24, 2012 at 09:30:59PM +0530,
vbanait@gmai... wrote:
> On windows, I added a substance mebeverine sr 150 mg , added brand
> ***ease and used it for one patient. I realised that mebeverine sr
> comes as 200 mg. and tried to correct it without success.
That's right. GNUmed will not let you edit a substance or
brand as long as it is in use with a patient. Allowing that
would be a patient safety issue.
> Tried to delete it without success.
Same as with editing. It would be a patient safety issue.
> Added a new substance entry of mebeverine
> sr 200 mg and added ***ease with 200 mg as substance. Now when i
> attempt to add morease sr 200 mg, only the entry of 150 mg is
> displayed and 200 mg is not accepted. That simply means that a brand
> name with a single substance with two different dosages can not be
> accepted by gnumed.
That is correct. GNUmed will not allow the user to use
identical names for different drugs.
Doing so would be a patient safety issue.
One will need to call each unique drug by a unique name.
Everything else would be a patient safety issue. Yes, drug
companies are patient safety issues, as we all know.
My suggestion would be to call the drugs
***ease 150
***ease 200
Karsten
--
GPG key ID E4071346 @ gpg-keyserver.de
E167 67FD A291 2BEA 73BD 4537 78B9 A9F9 E407 1346
_______________________________________________
Gnumed-devel mailing list
Gnumed-devel@gnu....
https://lists.gnu.org/mailman/listinfo/gnumed-devel
opensubscriber is not affiliated with the authors of this message nor responsible for its content.